Barclays »

Aeon Biopharma shares owned by Barclays

Quarter-by-quarter ownership of Aeon Biopharma (AEON) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Aeon Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $16 21 0.81

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Aeon Biopharma

Dauntless Investment Group
Vanguard Group
Geode Capital Management
Blue Owl Capital Holdings
Intl Fcstone
XTX Topco
Jane Street
BlackRock
UBS Group
DuPont Capital Management Corporation
Morgan Stanley
SBI Securities
Steward Partners Investment Advisory
GHP Investment Advisors
Wells Fargo & Company

View all funds holding Aeon Biopharma